RT Journal Article
SR Electronic
T1 The impact of opening dedicated clinics on disease transmission during an influenza pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20099622
DO 10.1101/2020.05.13.20099622
A1 Shi, Pengyi
A1 Yan, Jia
A1 Keskinocak, Pinar
A1 Shane, Andi L.
A1 Swann, Julie L.
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.13.20099622.abstract
AB Dedicated clinics can be established in an influenza pandemic to isolate people and potentially reduce opportunities for influenza transmission. However, their operation requires resources and their existence may attract the worried-well. In this study, we quantify the impact of opening dedicated influenza clinics during a pandemic based on an agent-based simulation model across a time-varying social network of households, workplaces, schools, community locations, and health facilities in the state of Georgia. We calculate performance measures, including peak prevalence and total attack rate, while accounting for clinic operations, including timing and location. We find that opening clinics can reduce disease spread and hospitalizations even when visited by the worried-well, open for limited weeks, or open in limited locations, and especially when the clinics are in operation during times of highest prevalence. Specifically, peak prevalence, total attack rate, and hospitalization reduced 0.07-0.32%, 0.40-1.51%, 0.02-0.09%, respectively, by operating clinics for the pandemic duration.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has been supported in part by a seed grant from Georgia Tech and by the following Georgia Tech benefactors: William W. George, Andrea Laliberte, Claudia L. and J. Paul Raines, and Richard E. “Rick” and Charlene Zalesky. This research has also been supported by Edward P. Fitts and the A. Doug Allison Distinguished Professorship. Any opinions, findings, conclusions, or recommendations are those of the authors and do not necessarily reflect the views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are fully available without restriction